LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.93 | 27.76 | 596 | 4421 | 0.1348 | 0.5208 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.93 | 27.76 | 5379 | 4421 | 1.2166 | 1.0543 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.93 | 27.76 | 1253 | 4421 | 0.2834 | 0.6833 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.93 | 27.76 | 5164 | 4421 | 1.1679 | 1.0429 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.63 | 27.76 | 747 | 4818 | 0.1550 | 0.5567 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.63 | 27.76 | 5754 | 4818 | 1.1943 | 1.0483 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.63 | 27.76 | 1461 | 4818 | 0.3032 | 0.7036 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.63 | 27.76 | 5547 | 4818 | 1.1513 | 1.0382 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.33 | 27.76 | 804 | 5117 | 0.1571 | 0.5640 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.33 | 27.76 | 6207 | 5117 | 1.2130 | 1.0520 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.33 | 27.76 | 1517 | 5117 | 0.2965 | 0.7017 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.33 | 27.76 | 5861 | 5117 | 1.1454 | 1.0364 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.04 | 27.76 | 786 | 5365 | 0.1465 | 0.5531 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.04 | 27.76 | 6465 | 5365 | 1.2049 | 1.0497 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.04 | 27.76 | 1778 | 5365 | 0.3314 | 0.7293 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.04 | 27.76 | 6244 | 5365 | 1.1637 | 1.0403 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.74 | 27.76 | 808 | 5606 | 0.1441 | 0.5530 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.74 | 27.76 | 6844 | 5606 | 1.2207 | 1.0528 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.74 | 27.76 | 1832 | 5606 | 0.3268 | 0.7282 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 54.74 | 27.76 | 6634 | 5606 | 1.1833 | 1.0444 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.45 | 27.76 | 865 | 5745 | 0.1506 | 0.5637 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.45 | 27.76 | 7208 | 5745 | 1.2546 | 1.0598 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.45 | 27.76 | 1876 | 5745 | 0.3265 | 0.7292 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 56.45 | 27.76 | 6944 | 5745 | 1.2086 | 1.0499 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.15 | 27.76 | 871 | 5906 | 0.1475 | 0.5615 | MN20160318_Q01 | L18 |